|
Neues Interview mit CEO Doug Janzen auf Youtube vom 10.10.2018 Aequus Pharmaceuticals (CVE: AQS) CEO Doug Janzen joined Steve Darling in the Vancouver Proactive studio to give details about his company. Those details include drugs already at market and others in the pipeline. Janzen also shared information on those drugs, Aequus 1303 which is being developed to help pregnant women with nausea. https://www.youtube.com/watch?v=lEyXdu9ME84 |
|
| aus der Diskussion: | AQS.V (Mkap c$13.5 M) 2 Produkte am Markt + 3 weitere kurz vor Zulassungsantrag |
| Autor (Datum des Eintrages): | Hart-Mann (12.10.18 10:46:39) |
| Beitrag: | 1,389 von 4,347 (ID:58940490) |
| Alle Angaben ohne Gewähr © wallstreetONLINE | |